These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9264325)

  • 21. Transcriptional repression of the microphthalmia gene in melanoma cells correlates with the unresponsiveness of target genes to ectopic microphthalmia-associated transcription factor.
    Vachtenheim J; Novotna H; Ghanem G
    J Invest Dermatol; 2001 Dec; 117(6):1505-11. PubMed ID: 11886515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of endothelin B receptor in human melanoma cell lines parallel to differentiation genes.
    Eberle J; Weitmann S; Thieck O; Pech H; Paul M; Orfanos CE
    J Invest Dermatol; 1999 Jun; 112(6):925-32. PubMed ID: 10383740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Azelaic acid was sensitizing effect in the chemotherapeutic treatment of several melanoma cell lines.
    Rodriguez-Vicente J; Vicente-Ortega V; Canteras-Jordana
    Pigment Cell Res; 1996 Dec; 9(6):317-25. PubMed ID: 9125756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of microtubule-associated protein 2 in benign and malignant melanocytes: implications for differentiation and progression of cutaneous melanoma.
    Fang D; Hallman J; Sangha N; Kute TE; Hammarback JA; White WL; Setaluri V
    Am J Pathol; 2001 Jun; 158(6):2107-15. PubMed ID: 11395388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of L-carnitine on cultured murine melanoma cells exposed to azelaic acid.
    Ward BJ; Breathnach AS; Robins EJ; Bhasin YP; Ethridge L; Nazzaro-Porro M; Passi S
    J Invest Dermatol; 1986 Apr; 86(4):438-41. PubMed ID: 3745962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of dicarboxylic acids on normal and malignant melanocytes in culture.
    Hu F; Mah K; Teramura DJ
    Br J Dermatol; 1986 Jan; 114(1):17-26. PubMed ID: 3942687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical mechanism of acetylsalicylic acid (Aspirin) selective toxicity toward melanoma cell lines.
    Vad NM; Yount G; Moridani MY
    Melanoma Res; 2008 Dec; 18(6):386-99. PubMed ID: 18971789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human melanoma cells sensitive to deoxyadenosine and deoxyinosine.
    Parsons PG; Hayward IP
    Biochem Pharmacol; 1986 Feb; 35(4):655-60. PubMed ID: 3004507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Azelaic acid: mode of action at cellular and subcellular levels.
    Galhaup I
    Acta Derm Venereol Suppl (Stockh); 1989; 143():75-82. PubMed ID: 2475996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of dicarboxylic acids on normal human melanocytes in dispersed tissue culture.
    Breathnach AS; Martin B; Nazzaro Porro M; Passi S; Mann P; Cooper J; Morpurgo G
    Br J Dermatol; 1979 Dec; 101(6):641-9. PubMed ID: 534609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis, potency, and cytoselectivity of anticancer agents derived by parallel synthesis from alpha-aminosuberic acid.
    Kahnberg P; Lucke AJ; Glenn MP; Boyle GM; Tyndall JD; Parsons PG; Fairlie DP
    J Med Chem; 2006 Dec; 49(26):7611-22. PubMed ID: 17181145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Azelaic acid: potential as a general antitumoural agent.
    Breathnach AS
    Med Hypotheses; 1999 Mar; 52(3):221-6. PubMed ID: 10362281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitors of mammalian melanocyte tyrosinase: in vitro comparisons of alkyl esters of gentisic acid with other putative inhibitors.
    Curto EV; Kwong C; Hermersdörfer H; Glatt H; Santis C; Virador V; Hearing VJ; Dooley TP
    Biochem Pharmacol; 1999 Mar; 57(6):663-72. PubMed ID: 10037452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of the cyclic AMP pathway by alpha-melanotropin mediates the response of human melanocytes to ultraviolet B radiation.
    Im S; Moro O; Peng F; Medrano EE; Cornelius J; Babcock G; Nordlund JJ; Abdel-Malek ZA
    Cancer Res; 1998 Jan; 58(1):47-54. PubMed ID: 9426056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of transiently transfected reporter genes in 3T3 Swiss cells by the inducers of differentiation/apoptosis--dimethylsulfoxide, hexamethylene bisacetamide and trichostatin A.
    Ishiguro K; Sartorelli AC
    Eur J Biochem; 2004 Jun; 271(12):2379-90. PubMed ID: 15182353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tyrosinase-related proteins suppress tyrosinase-mediated cell death of melanocytes and melanoma cells.
    Rad HH; Yamashita T; Jin HY; Hirosaki K; Wakamatsu K; Ito S; Jimbow K
    Exp Cell Res; 2004 Aug; 298(2):317-28. PubMed ID: 15265682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Azelaic acid vs. placebo: effects on normal human keratinocytes and melanocytes. Electron microscopic evaluation after long-term application in vivo.
    Mayer-da Silva A; Gollnick H; Imcke E; Orfanos CE
    Acta Derm Venereol; 1987; 67(2):116-22. PubMed ID: 2438874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimelanoma effect of 4-S-cysteaminylcatechol, an activated form of 4-S-cysteaminylphenol.
    Inoue S; Hasegawa K; Ito S; Ozeki H; Solano F; Jiménez-Cervantes C; Wakamatsu K; Fujita K
    Cancer Res; 1995 Jun; 55(12):2603-7. PubMed ID: 7780975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of different antineoplastic agents and of pretreatment by modulators on three melanoma lines.
    Rodriguez-Vicente J; Vicente-Ortega V; Canteras-Jordana M
    Cancer; 1998 Feb; 82(3):495-502. PubMed ID: 9452267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Up-regulation of p21(WAF1/CIP1) by histone deacetylase inhibitors reduces their cytotoxicity.
    Burgess AJ; Pavey S; Warrener R; Hunter LJ; Piva TJ; Musgrove EA; Saunders N; Parsons PG; Gabrielli BG
    Mol Pharmacol; 2001 Oct; 60(4):828-37. PubMed ID: 11562446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.